Before taking Cyclobenzaprine
Do not take Cyclobenzaprine if you have used an MAO inhibitor such as isocarboxazid (Marplan), tranylcypromine (Parnate), phenelzine (Nardil), or selegiline (Eldepryl, Emsam) within the past 14 days. Serious, life-threatening side effects can occur if you take Cyclobenzaprine before the MAO inhibitor has cleared from your body. Do not use Cyclobenzaprine if you have recently had a heart attack, or if you have:
* a heart rhythm disorder;
* congestive heart failure;
* heart block; or
* an overactive thyroid.
Before using Cyclobenzaprine, tell your doctor if you are allergic to any drugs, or if you have:
* problems with urination;
* enlarged prostate;
* glaucoma; or
* liver disease.
If you have any of these conditions, you may need a dose adjustment or special tests to safely take Cyclobenzaprine.
Cyclobenzaprine FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether Cyclobenzaprine passes into breast milk or if it could harm a nursing baby. Do not use Cyclobenzaprine without telling your doctor if you are breast-feeding a baby.
Older adults may be more sensitive to the side effects of Cyclobenzaprine.
Related posts:
